Stephen Brigido - 13 Apr 2026 Form 4 Insider Report for Celularity Inc (CELU)

Reporting relationship: Pres., Functional Regeneration
Issuer ticker: CELU
Reported as of: 13 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Apr 2026, 16:30:25 UTC
Prior SEC filing: 15 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen Brigido

Key filing fact

Stephen Brigido filed Form 4 for Celularity Inc (CELU) on 15 Apr 2026.

Key facts

This page summarizes Stephen Brigido's Form 4 filing for Celularity Inc (CELU).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Apr 2026, 16:30.

Change

Previous filing in this sequence was filed on 15 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001869791 Primary reporting owner

Brigido Stephen

Relationship: Pres., Functional Regeneration
Address: C/O CELULARITY INC., 170 PARK AVENUE, FLORHAM PARK
Signature: /s/ Stephen Brigido
Signature date: 15 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CELU transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +821
Change %: +9.2%
Price: $0.000000^*
Shares after: 9,742
Date: 13 Apr 2026
Ownership: Direct
Footnotes: F1

CELU transaction

Class A Common Stock

Tax liability

Transaction value
Shares: -268
Change %: -2.8%
Price: $1.28^*
Shares after: 9,474
Date: 13 Apr 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CELU transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -821
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 13 Apr 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 821
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.

Footnote F2

This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026.

Footnote F3

Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.

Footnote F4

On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4.